Wyndham Hotels & Resorts (WH) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
18 Jan, 2026Executive summary
Achieved strong Q3 results with 4% global room growth, 8% international growth, and 1% U.S. growth, driven by system expansion, higher royalty rates, and robust ancillary fee streams.
Opened over 17,000 rooms in Q3, bringing year-to-date global openings to 48,000 rooms, up 13% from last year.
Franchisee retention rate improved by 40 basis points year-over-year, reaching 95.7% globally.
Development pipeline reached a record 248,000 rooms, up 5% year-over-year, with 197 new contracts awarded in Q3.
The company incurred $42 million in transaction-related costs due to a failed hostile takeover defense in 2024.
Financial highlights
Q3 2024 adjusted EBITDA was $208 million, up 4% year-over-year; adjusted diluted EPS was $1.39, up 10% year-over-year on a comparable basis.
Q3 fee-related and other revenues were $394 million; net income was $102 million, down 1% year-over-year.
Adjusted Free Cash Flow was $96 million in Q3 and $267 million year-to-date, with a 51% conversion rate from Adjusted EBITDA.
Returned $126 million to shareholders in Q3 via $97 million in share repurchases and $29 million in dividends.
$377 million in capital returned to shareholders year-to-date 2024.
Outlook and guidance
Increased full-year Adjusted diluted EPS guidance to $4.22–$4.34 and Adjusted EBITDA guidance to $690–$700 million.
Full-year 2024 room growth expected at 3–4%; global RevPAR growth expected to be approximately flat.
Free cash flow conversion is expected to be around 60% for 2024.
Anticipate continued positive momentum into 2025, supported by infrastructure-related business and easier comps.
Outlook excludes expenses related to the defense of a hostile takeover attempt.
Latest events from Wyndham Hotels & Resorts
- Strong 2025 results, robust governance, and ESG focus; board opposes written consent proposal.WH
Proxy filing25 Mar 2026 - Annual meeting to vote on directors, pay, auditor, and written consent proposal.WH
Proxy filing25 Mar 2026 - Record room growth, resilient earnings, and strong capital returns despite RevPAR headwinds.WH
Q4 202519 Feb 2026 - Q2 saw 4% room growth, 22% higher adjusted EPS, and record pipeline expansion.WH
Q2 20242 Feb 2026 - Record system growth, strong earnings, and new initiatives drive a positive 2025 outlook.WH
Q4 202429 Dec 2025 - Record growth, strong financials, and robust governance drive positive outlook for 2025.WH
Proxy Filing1 Dec 2025 - Director elections, executive pay, and auditor ratification headline the annual meeting agenda.WH
Proxy Filing1 Dec 2025 - Record room and pipeline growth, but 2025 guidance lowered on RevPAR softness.WH
Q1 20251 Dec 2025 - System and pipeline growth offset RevPAR declines, driving higher earnings and strong cash returns.WH
Q3 202524 Oct 2025